Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma (Q36145839)

12 August 2017

1 reference

title

Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma (English)

1 reference

chronic obstructive pulmonary disease

12 August 2017

1 reference

1 reference

Peter Jeffery

1

1 reference

PubMed ID

15926868

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

14

1 reference

12 August 2017

5

1 reference

12 August 2017

619-632

1 reference

Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Asthma. From bronchoconstriction to airways inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Inflammatory mediation of airway hyperresponsiveness by peripheral blood granulocytes. The case for the eosinophil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Cytokines. 3. Cytokines in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Mast-cell infiltration of airway smooth muscle in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Cellular and structural bases of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Amplification of inflammation in emphysema and its association with latent adenoviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Bacterial infection in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Inhibition of nitric oxide synthase by nasal decongestants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

The TORCH (towards a revolution in COPD health) survival study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Use of inhaled corticosteroids and risk of fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

A population based case-control study of cataract and inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.5.619

10.1517/13543784.14.5.619

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15926868